Crash Course in Cures: Menin-Inhibitors  image

Crash Course in Cures: Menin-Inhibitors

Can't make it to the event?
We send a recording to all registered participants of the event!
Aug 21, 2026
12:00PM - 01:00PM EDT
Online Event
Overview

Menin-Inhibitors are a breakthrough treatment for AML patients. Join HealthTree as we learn more about Menin-Inhibitors and the ones that are already on the market with Dr. Catherine Lai.

 

Agenda
12:00 PM
Introduction
Eliza Prickett

Eliza introduces the agenda of the event and our featured speaker Dr. Catherine Lai

12:05 PM
Presentation
Catherine Lai, MD, MPH

Dr. Lai talks about Menin-Inhibitors

12:35 PM
Questions and Answers
Audience

Come with your questions and we'll answer them!

Speakers & Moderators
Healthtree contact Eliza Prickett

Eliza Prickett

Eliza joined HealthTree in March 2026 as the Leukemia Patient Health Education Manager. Prior to joining HealthTree, she completed a Master’s Degree in Public Health from Brigham Young University and worked with a variety of underserved populations in government and healthcare settings, including Americorps and Utah Health Department. When not in office, Eliza enjoys reading, writing and learning new things about the world.
Healthtree contact Catherine Lai, MD, MPH

Catherine Lai, MD, MPH

After completing internal medicine residency at the University of Illinois Chicago, Dr. Lai completed a fellowship in hematology/oncology at the National Cancer Institute of the National Institutes of Health. Dr. Lai also received her master’s in Public Health in Epidemiology from George Washington University. Prior to joining Penn, Dr. Lai served as the Director of Leukemia at MedStar Georgetown University Hospital’s Lombardi Comprehensive Cancer Center in Washington, DC. In her current role, she is the Physician Leader of the Leukemia Clinical Research Unit and Medical Director of the outpatient hematologic malignancies clinic. She is also Co- Director of the Penn Geriatric Oncology Core which focuses on the complete care of older adults with cancer.